Toronto Dominion Bank lowered its stake in Xylem Inc. (NYSE:XYL – Get Rating) by 41.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 106,347 shares of the industrial products company’s stock after selling 73,794 shares during the period. Toronto Dominion Bank’s holdings in Xylem were worth $12,753,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. AGF Investments LLC bought a new position in shares of Xylem in the fourth quarter valued at $27,000. Bell Investment Advisors Inc acquired a new stake in Xylem during the 3rd quarter valued at $32,000. Massmutual Trust Co. FSB ADV raised its stake in Xylem by 503.8% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 320 shares of the industrial products company’s stock valued at $40,000 after purchasing an additional 267 shares during the period. Bedel Financial Consulting Inc. raised its stake in Xylem by 99.5% during the 4th quarter. Bedel Financial Consulting Inc. now owns 401 shares of the industrial products company’s stock valued at $48,000 after purchasing an additional 200 shares during the period. Finally, Lindbrook Capital LLC raised its stake in Xylem by 64.3% during the 4th quarter. Lindbrook Capital LLC now owns 424 shares of the industrial products company’s stock valued at $51,000 after purchasing an additional 166 shares during the period. 83.99% of the stock is currently owned by institutional investors.
XYL has been the topic of several recent analyst reports. Stifel Nicolaus cut their target price on shares of Xylem from $100.00 to $90.00 and set a “hold” rating on the stock in a research note on Monday. StockNews.com initiated coverage on shares of Xylem in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. TheStreet downgraded shares of Xylem from a “b” rating to a “c+” rating in a research note on Monday, February 7th. Credit Suisse Group dropped their price target on shares of Xylem from $111.00 to $98.00 and set an “underperform” rating on the stock in a research note on Friday, February 4th. Finally, Zacks Investment Research raised shares of Xylem from a “strong sell” rating to a “hold” rating and set a $92.00 target price on the stock in a research report on Wednesday, April 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $114.45.
Xylem (NYSE:XYL – Get Rating) last announced its earnings results on Thursday, February 3rd. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.01. Xylem had a net margin of 8.22% and a return on equity of 14.67%. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the previous year, the firm posted $0.81 earnings per share. Xylem’s revenue was down 3.6% compared to the same quarter last year. Research analysts predict that Xylem Inc. will post 2.57 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, March 17th. Investors of record on Thursday, February 17th were given a dividend of $0.30 per share. The ex-dividend date was Wednesday, February 16th. This represents a $1.20 dividend on an annualized basis and a yield of 1.45%. This is a positive change from Xylem’s previous quarterly dividend of $0.28. Xylem’s payout ratio is 51.06%.
Xylem Company Profile (Get Rating)
Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.
- Get a free copy of the StockNews.com research report on Xylem (XYL)
- 3 No-Brainer Stocks to Buy with $1000
- Rite Aid Stock is Getting Cheap Enough to Buy Here
- Analysts Reel In Netflix Targets Ahead Of Q1 Earnings
- MarketBeat Podcast: Making Money in the Red-Hot Housing Market
- Banking On Bank Of America
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.